46. Malignant rheumatoid arthritis Clinical trials / Disease details
Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02643823 (ClinicalTrials.gov) | January 2016 | 23/12/2015 | Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis | Safety and Efficacy Study of Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis | Rheumatoid Arthritis | Biological: hUC-MSC + DMARDs;Drug: DMARDs | Shenzhen Hornetcorn Bio-technology Company, LTD | Futian People's Hospital | Recruiting | 18 Years | 80 Years | Both | 40 | Phase 1 | China |